Related Experiment Video
Updated: May 22, 2026

Porphyromonas gingivalis as a Model Organism for Assessing Interaction of Anaerobic Bacteria with Host Cells
Published on: December 17, 2015
Doxycycline inhibits TREM-1 induction by Porphyromonas gingivalis
Nagihan Bostanci1, Georgios N Belibasakis
1Oral Translational Research, Institute of Oral Biology, Center of Dental Medicine, University of Zürich, Switzerland. nagihan.bostanci@zzm.uzh.ch
Abstract:
The triggering receptor expressed on myeloid cells 1 (TREM-1) is a cell surface receptor of the immunoglobulin superfamily, with the capacity to amplify pro-inflammatory cytokine production. Porphyromonas gingivalis is a Gram-negative anaerobic species highly implicated in inflammatory periodontal disease, with potential involvement in systemic inflammation. Porphyromonas gingivalis positively regulates TREM-1 expression and production in monocytic cells. Subantimicrobial doses of doxycycline (SDD) are used as an adjunct treatment in periodontal therapy, because of their anti-inflammatory properties. The aim of this study was to investigate the effect of SDD on P. gingivalis-induced TREM-1 expression and secretion by the myelomonocytic cell line MonoMac-6. After 24 h of challenge, P. gingivalis enhanced TREM-1 gene expression by the cells, with a concomitant increase in soluble TREM-1 release. Nevertheless, SDD concentrations between 2 and 10 μg mL(-1) abolished TREM-1 expression and release, already after 4 h of administration. Moreover, SDD reduced P. gingivalis-induced interleukin-8 secretion, confirming its anti-inflammatory effects. In conclusion, SDD inhibits bacterially induced TREM-1, and this effect may partly account for its generalized anti-inflammatory properties. This could partly explain the clinical efficacy of SDD as an adjunctive treatment for periodontal disease, but may also indicate that SDD could serve as a suitable modulator of systemic inflammatory responses.
Insights
Subantimicrobial doses of doxycycline (SDD) reduce the expression and release of triggering receptor expressed on myeloid cells 1 (TREM-1) induced by Porphyromonas gingivalis. This anti-inflammatory effect may explain SDD
Area of Science:
- Immunology
- Microbiology
- Periodontology
Background:
- Triggering receptor expressed on myeloid cells 1 (TREM-1) amplifies pro-inflammatory cytokine production.
- Porphyromonas gingivalis is linked to periodontal and systemic inflammation.
- Subantimicrobial doses of doxycycline (SDD) possess anti-inflammatory properties used in periodontal therapy.
Purpose of the Study:
- To investigate the impact of SDD on P. gingivalis-induced TREM-1 expression and secretion.
- To evaluate the anti-inflammatory effects of SDD in a cellular model of periodontal disease.
Main Methods:
- Exposure of MonoMac-6 cells to P. gingivalis.
- Treatment with varying concentrations of SDD.
- Measurement of TREM-1 gene expression, soluble TREM-1 release, and interleukin-8 secretion.
Main Results:
- P. gingivalis significantly increased TREM-1 expression and soluble TREM-1 release.
- SDD (2-10 μg/mL) inhibited P. gingivalis-induced TREM-1 expression and release within 4 hours.
- SDD reduced P. gingivalis-induced interleukin-8 secretion.
Conclusions:
- SDD effectively inhibits P. gingivalis-induced TREM-1.
- Inhibition of TREM-1 may contribute to the anti-inflammatory effects of SDD in periodontal disease.
- SDD could potentially modulate systemic inflammatory responses.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Gram-positive Cell Wall Synthesis
The Oral Microbiota
Bacterial Phylum Spirochaetes
Inhibitors of Bacterial Protein Synthesis

